Holen Sie sich die Stockscreener-App
31.79
0.60%
0.19
Handel nachbörslich:
31.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
Enovis to Participate in Upcoming Investor Conferences | ENOV Stock News - GuruFocus
Enovis Corporation Management to Participate in Upcoming Investor Conferences - Nasdaq
Enovis Leadership Brings Medical Technology Innovation Story to Major Healthcare Conferences - Stock Titan
Enovis Corp (ENOV) Stock Price Down 3.51% on Jun 2 - GuruFocus
Optimistic Buy Rating for Enovis: Strong Growth, Margin Expansion, and Attractive Valuation - TipRanks
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Orthopedic Braces & Supports Market Focused Insights - GlobeNewswire
Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor - Yahoo Finance
Enovis Corp (ENOV) Trading Down 3.12% on May 21 - GuruFocus
Enovis holds annual meeting, stockholders vote on proposals By Investing.com - Investing.com India
Enovis holds annual meeting, stockholders vote on proposals - Investing.com
Enovis Holds Annual Meeting, Elects Board Directors - TipRanks
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) - Yahoo Finance
Canaccord cuts Enovis stock target to $70, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Enovis stock target to $70, maintains Buy rating - Investing.com Australia
Enovis (ENOV): Canaccord Genuity Lowers Price Target to $70 | EN - GuruFocus
Canaccord Adjusts Price Target for Enovis (ENOV) Following Q1 Re - GuruFocus
Enovis price target lowered to $70 from $75 at Canaccord - TipRanks
Enovis Corporation (NYSE:ENOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Conflicted on These Industrial Goods Names: Carrier Global (CARR), BrightView Holdings (BV) and Enovis (ENOV) - The Globe and Mail
Enovis Corporation’s Strong Q1 2025 Earnings Call - TipRanks
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating - marketscreener.com
JMP Securities Cuts Enovis (NYSE:ENOV) Price Target to $55.00 - Defense World
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - MSN
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
Analysts Offer Insights on Industrial Goods Companies: Enovis (ENOV), Boeing (BA) and Arlo Technologies (ARLO) - The Globe and Mail
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Enovis stock price target cut to $55 by JMP Securities - Investing.com South Africa
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis: Q1 Earnings Snapshot - New Haven Register
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges - Yahoo Finance
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges By GuruFocus - Investing.com Canada
Enovis Corporation Reports Strong Q1 2025 Growth - TipRanks
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Transcript : Enovis Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Enovis CORP SEC 10-Q Report - TradingView
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):